The Society of Interventional Radiology's government relations and health policy staff members work to further the interests of society members by advocating on their behalf before Congress, regulatory and federal agencies and the White House.
SIR members play a vital role in this process. This section will guide you through our advocacy efforts, the major policy issues that affect the society and how you can get involved.
The decisions Congress makes and the Centers for Medicare and Medicaid Services (CMS) implements, can have a profound effect on your practice and the health care you provide for your patients. SIR government affairs team advocates in Congress and the federal agencies to make sure that physician reimbursement for IR services are protected and enhanced. It is important for legislators and regulators to hear the voices of SIR members. SIR collaborates with members of Congress, CMS, and other medical and health care organizations to advocate for physician reimbursement issues. Among the robust collection of reimbursement issues SIR advocates on: the Medicare Physician Fee Schedule, insurance carrier advocacy, evaluation and management (E/M) coding and implementation of RUC recommendations beneficial to IR. For more information on physician reimbursement, please visit the SIR’s policy and economics page.
The decisions made by Congress and the administration’s COVID-19 Taskforce directly influence the current and future practice of IRs nationwide. SIR is actively advocating in Congress and the federal agencies to address the needs and concerns of our members related to the COVID-19 pandemic. The SIR government relations team is working to ensure IRs have access to PPE, workforce financial assistance, expanded telehealth with related payments and liability protections for those serving as frontline physicians. SIR has joined other medical specialty societies to communicate directly with CMS, the Department of Health and Human Services and Congress to advocate for financial and clinical support for IRs nationwide.
SIR signs onto a letter to Congress about H.R. 8505: Waiving Budget Neutrality
SIR joined the American College of Radiology (AMA) and other medical specialty societies to send a letter to Congress on October 9, 2020. The letter thanks Congressmen Michael Burgess, MD, and Bobby Rush for their leadership in introducing H.R. 8505, a bill to prevent pending Medicare payment cuts by waiving the budget neutrality requirements stipulated in Section 1848(c)(2) of the Social Security Act for the finalized evaluation and management (E/M) code proposal slated for implementation on January 1, 2021.
SIR submits comments to FDA about Polidocanol products
SIR submitted a comment letter to the FDA on Sept. 29, 2020. SIR's letter supports the FDA in its re-evaluation efforts and offers information on two venous pathologies with needs that are unmet by the commercially available agents.
SIR signs onto a letter to Congress opposing H.R. 884: Medicare Mental Health Access Act
SIR joined the American Medical Association (AMA) and other medical specialty societies to send a letter to Congress on September 22, 2020. The letter urges Congress to oppose H.R. 884, which would change the definition of “physician” under the Medicare program to include clinical psychologists.
SIR and ACR submit comments jointly on Peripheral Vascular Atherectomy Medical Devices.
SIR and the College of American Radiology submitted a joint comment letter to the FDA on Sept. 11, 2020. The letter supports the FDA in its efforts to update the FDA Guidance Document on Peripheral Vascular Atherectomy Devices- Premarket [510 (k)] Submissions to create a greater degree of clinical safety and device operational predictability.
When: Nov. 11, 2020 from 8 p.m.–9 p.m. ET
Voices for IR is SIR's new grassroots advocacy program designed to amplify our communications on issues affecting interventional radiologists nationwide. Voices for IR allows member volunteers to serve as an extension of SIR's advocacy team to help achieve our legislative and regulatory goals.